<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04833569</url>
  </required_header>
  <id_info>
    <org_study_id>KingSaud</org_study_id>
    <nct_id>NCT04833569</nct_id>
  </id_info>
  <brief_title>ICG-PDT, Periimplantitis, Diabetes Mellitus</brief_title>
  <official_title>Clinical, Bacterial, and Inflammatory Outcomes of Indocyanine Green-mediated Photodynamic Therapy for Treating Periimplantitis Among Diabetic Patients: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Saud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>King Saud University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the effect of photodynamic therapy (indocyanine green mediated) on the&#xD;
      clinical, biological and inflammatory aspects was assessed in diabetic patients having&#xD;
      peri-implantitis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 20, 2020</start_date>
  <completion_date type="Actual">March 10, 2021</completion_date>
  <primary_completion_date type="Actual">February 15, 2021</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>6 months</time_frame>
    <description>Presence or absence of bleeding indicated as '1' or '0', respectively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plaque index</measure>
    <time_frame>6 months</time_frame>
    <description>Presence or absence of plaque indicated as '1' or '0', respectively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Probing depth</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of consecutive millimeter markings of the periodontal pocket depth</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Suppuration</measure>
    <time_frame>6 months</time_frame>
    <description>Presence or absence of pus</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Crestal bone loss</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of consecutive millimeter markings of the alveolar bone levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiological analysis (Porphyromonas gingivalis)</measure>
    <time_frame>6 months</time_frame>
    <description>Bacterial viability from the peri-implant plaque</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microbiological analysis (Treponema denticola)</measure>
    <time_frame>6 months</time_frame>
    <description>Bacterial viability from the peri-implant plaque</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of serum HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-1 beta</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment from peri-implant crevicular fluid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-6</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment from peri-implant crevicular fluid</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Indocyanine green mediated photodynamic therapy (ICG-PDT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Delivery of ICG solution at a concentration of 1 mg/mL will be used. The photosensitizer will be applied until the bottom of the peri-implant pocket using a 1 ml syringe. An 810 nm diode laser (A.R.C. laser GmbH, Nurnberg, Germany) with a power of 200 mW (continuous mode) and total energy of 4 J will be used to excite the ICG by starting from the papilla for 30 s followed by the insertion inside the peri-implant pocket depth for 10 s from both buccal and lingual side moving to coronal direction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peri-implant mechanical debridement</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-surgical peri-implant mechanical debridement (PIMD) through ultrasonic device with a carbon tip.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ICG-PDT</intervention_name>
    <description>An 810 nm diode laser (A.R.C. laser GmbH, Nurnberg, Germany) with a power of 200 mW (continuous mode) and total energy of 4 J was used to excite the ICG by starting from the papilla for 30 s followed by the insertion inside the peri-implant pocket depth for 10 s from both buccal and lingual side moving to coronal direction. The treatment was applied according to the manufacturer's recommendation. The PDT was performed by a single operator in all test patients</description>
    <arm_group_label>Indocyanine green mediated photodynamic therapy (ICG-PDT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>peri-implant mechanical debridement</intervention_name>
    <description>The peri-implant mechanical debridement was done with the help of ultrasonic carbon tip (Vector, Durr Dental, Bietigheim-Bissingen, Germany).</description>
    <arm_group_label>Indocyanine green mediated photodynamic therapy (ICG-PDT)</arm_group_label>
    <arm_group_label>Peri-implant mechanical debridement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:&#xD;
&#xD;
               -  adult patients above 45 years of age having type 2 DM&#xD;
&#xD;
               -  HbA1c (≥6.5%) and fasting glucose test&#xD;
&#xD;
               -  probing depth ≥6 mm with bleeding and/or suppuration on at least one site around&#xD;
                  dental implants that remained in situ&#xD;
&#xD;
               -  On radiographic assessment, the implants exhibited ≥ 3 mm alveolar bone loss&#xD;
                  apical to the coronal region of the intraosteal portion of the dental implant.&#xD;
&#xD;
          -  Exclusion Criteria Patients were excluded if they indicated current or former history&#xD;
             of tobacco smoking, any systemic disease other than DM, enrolled in a non-surgical&#xD;
             periodontal maintenance program, history of implant repair, pregnancy, and part six&#xD;
             months use of antimicrobials, non-steroidal anti-inflammatory drugs, bisphosphonates,&#xD;
             or corticosteroids.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nawwaf Labban, BDS MSD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Saud University</name>
      <address>
        <city>Riyadh</city>
        <zip>11564</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2021</study_first_posted>
  <last_update_submitted>April 4, 2021</last_update_submitted>
  <last_update_submitted_qc>April 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King Saud University</investigator_affiliation>
    <investigator_full_name>Labban Nawwaf</investigator_full_name>
    <investigator_title>Department of Prosthetic Dental Sciences, College of Dentistry, King Saud University</investigator_title>
  </responsible_party>
  <keyword>photodynamic therapy*</keyword>
  <keyword>periimplantitis*</keyword>
  <keyword>diabetes mellitus*</keyword>
  <keyword>indocyanine green*</keyword>
  <keyword>photosensitizer*</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

